STERILE PREPARATIONS RELATED ARTICLES |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 358-362
|
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
|
Sep/Oct 2024
Pg. 383-393
|
Sterile Basics of Compounding: Repackaging, Part 1
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 298-303
|
Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing
Akers Michael J
|
May/Jun 2024
Pg. 229-240
|
Sterile Filtration
Akers Michael J
|
Mar/Apr 2024
Pg. 120-127
|
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
|
Jan/Feb 2024
Pg. 44-55
|
Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 483-486
|
Hyaluronidase Injection
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 491
|
Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 397-409
|
Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 305-313
|
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
|
May/Jun 2023
Pg. 223-229
|
Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility
Summers Amy
|
Mar/Apr 2023
Pg. 114-121
|
Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 123-139
|
Aminohippurate Sodium 250 mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 142
|
Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes
de Wilde Sofieke, Crul Mirjam, Breukels Oscar
|
Mar/Apr 2023
Pg. 154-159
|
Sterile Basics: How to Know if Your Cleanroom Can Consistently Operate Within a State of Control
Summers Amy, Stephens Pat
|
Jan/Feb 2023
Pg. 39-46
|
Sterile Basics of Compounding: Contamination Control Strategies, Part 2
Summers Amy
|
Nov/Dec 2022
Pg. 497-504
|
Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding)
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 515
|
Sterile Basics of Compounding: Contamination Control Strategies, Part 1
Summers Amy
|
Sep/Oct 2022
Pg. 411-418
|
Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program
Summers Amy
|
Jul/Aug 2022
Pg. 309-315
|
Three Things You Need to Know Right Now
Brunner Scott
|
May/Jun 2022
Pg. 211-213
|
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
|
May/Jun 2022
Pg. 219-228
|
Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine
Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
|
May/Jun 2022
Pg. 248-254
|
Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 118-126
|
Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 129-136
|
Pharmacy Student Satisfaction and Perceptions Following a Virtual Sterile Compounding Experience
Mohammad Insaf, Lobkovich Alison, Nardolillo Joseph, Wilhelm Shelia
|
Jan/Feb 2022
Pg. 10-17
|
Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 41-49
|
Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021
Hecq Jean-Daniel, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
|
Nov/Dec 2021
Pg. 446-462
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 491-496
|
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2
Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
|
Sep/Oct 2021
Pg. 389-395
|
Expecting the Expected: Planning Considerations for Cleanroom Construction
Roberts Patricia A, Kroon Laura
|
Jul/Aug 2021
Pg. 276-281
|
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1
Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
|
Jul/Aug 2021
Pg. 298-302
|
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 311-317
|
Pharmacy Technicians' Perceptions of Risk Reduction Strategies Implemented in Response to the Repetitive Strain Injury Associated with Sterile Compounding
Zamani Mazdak, Chan Kayin, Wilcox Julie
|
May/Jun 2021
Pg. 182-186
|
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
May/Jun 2021
Pg. 222-229
|
PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 92
|
Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic
Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
|
Mar/Apr 2021
Pg. 109-113
|
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 131-139
|
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
McKettrick Greg, Yoch Doug
|
Jan/Feb 2021
Pg. 18-23
|
Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 42
|
Establishing a Structured Pharmacy Training Program in Sterile Compounding
Dirbas Muhannad, AbuSara Aseel K, Whiyabi Shatha, Harb Rema, Telfah Shorouq
|
Nov/Dec 2020
Pg. 460-465
|
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 473-478
|
Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients
Nogales Luis Marcos, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol
|
Sep/Oct 2020
Pg. 358-364
|
Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection
(Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection
(Vet-Mouse)
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 406
|
Evaluation of the Efficacy and Superiority of Different Vial Rubber Closure Disinfection Techniques
Bjornstad Matthew, Kosinski Tracy, Burlage Robert
|
Sep/Oct 2020
Pg. 434-438
|
Quality Control: Rapid Sterility Testing for Compounding Pharmacies
Taylor Andrew
|
Jul/Aug 2020
Pg. 299-303
|
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 305-309
|
Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review
Milibari Loay, Cotugno Michael, Belisle Caryn, Rocchio Megan, Patterson Robert F, Chacon Pablo, Fanikos John, Vo Peter
|
Jul/Aug 2020
Pg. 346-351
|
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
Allen Loyd V Jr
|
May/Jun 2020
Pg. 215-220
|
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 121-126
|
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems
Vaughn Stacey R, Radwick Allison
|
Jan/Feb 2020
Pg. 14-19
|
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 44-50
|
Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators
Mulder Kyle
|
Nov/Dec 2019
Pg. 447-452
|
How to Qualify Container Closure Systems for Intended Use, Part 1
Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
|
Nov/Dec 2019
Pg. 454-461
|
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2
Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
|
Nov/Dec 2019
Pg. 467-471
|
Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 478-482
|
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1
Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
|
Sep/Oct 2019
Pg. 387-391
|
Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 399-402
|
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 299-303
|
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Allen Loyd V Jr
|
May/Jun 2019
Pg. 221-228
|
Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website
Sluggett Janet K, Johnson Michelle J, Zamani Mazdak, Kastango Eric S, Bodnar Mark, Cantor Peter, Hobbs Jodie G, Reynolds Karen J, Sluggett Andrew J
|
May/Jun 2019
Pg. 238-244
|
Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 123-130
|
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding
Martin Matt
|
Jan/Feb 2019
Pg. 47-49
|
Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2
Martin Matt
|
Nov/Dec 2018
Pg. 475-478
|
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018
Pg. 387-398
|
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
|
Sep/Oct 2018
Pg. 401-404
|
Cysteamine 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 408
|
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Martin Matt
|
Jul/Aug 2018
Pg. 303-312
|
Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding
Allen Loyd V Jr
|
May/Jun 2018
Pg. 206-217
|
Dorzolamide 2% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2018
Pg. 234
|
Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture
Allen Loyd V Jr
|
May/Jun 2018
Pg. 237
|
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy
Rhoads Rick
|
Mar/Apr 2018
Pg. 129-134
|
Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 147
|
Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 151
|
Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy
Kosinski Tracy M, Brown Michael C, Zavala Pedro J
|
Jan/Feb 2018
Pg. 41-46
|
Glutamate and Aspartate Cardioplegia Additive Solution
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 50
|
Sodium Citrate 9% Nasal Spray for Olfactory Disorders
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 57
|
Haloperidol 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 493
|
Trace Elements Injection 5
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 498
|
Vancomycin 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 499
|
Basics of Sterile Compounding: Particulate Matter
Akers Michael J
|
Sep/Oct 2017
Pg. 395-404
|
Acetylcysteine Solutions for Inhalation
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 408
|
Etoposide 20-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 410
|
Fentanyl Citrate 50-mcg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 411
|
Ioversol Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 413
|
Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 415
|
Tacrolimus 0.3-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 416
|
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes
Kirkham Kylian, Munson Jessica M, McCluskey Susan V, Graner Kevin K
|
Sep/Oct 2017
Pg. 426-429
|
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags
Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M
|
Sep/Oct 2017
Pg. 436-439
|
Component Selection for Sterile Compounding
Dilzer Richard H
|
Jul/Aug 2017
Pg. 277-280
|
Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
|
Jul/Aug 2017
Pg. 301-308
|
Reteplase Injection
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 317
|
Tacrolimus 0.06% Ophthalmic Drops
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 319
|
Torsemide 10-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 320
|
Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding
Ligugnana Roberto
|
May/Jun 2017
Pg. 182-190
|
Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Mixon William, Roth Abby
|
May/Jun 2017
Pg. 193-203
|
Basics of Sterile Compounding: Manipulating Peptides and Proteins
Akers Michael J
|
May/Jun 2017
Pg. 223-228
|
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
|
Mar/Apr 2017
Pg. 95-102
|
Accuracy Considerations in Sterile Compounding
Akers Michael J
|
Mar/Apr 2017
Pg. 133-142
|
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers
McCluskey Susan V, Kirkham Kylian, Munson Jessica M
|
Mar/Apr 2017
Pg. 150-153
|
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
|
Jan/Feb 2017
Pg. 47-56
|
Infliximab 1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 62
|
Tetracaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 64
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 495-500
|
Flumazenil 0.1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 509
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 399-404
|
Inamrinone 5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 408
|
Tromethamine Injection
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 415
|
Choosing a Vial Processing Line for Aseptic Compounding: Part 1
Noorian Shaun, Vahedi Navid
|
Jul/Aug 2016
Pg. 283-292
|
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding
Akers Michael J
|
Jul/Aug 2016
Pg. 307-314
|
Dolasetron Mesylate 20-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 318
|
Gatifloxacin 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 319
|
Plasmingen and Hyaluronate Sodium Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 325
|
Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 326
|
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Akers Michael J
|
May/Jun 2016
Pg. 217-222
|
Carboplatin 50-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 226
|
Cefotetan Disodium Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 227
|
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
|
May/Jun 2016
Pg. 228
|
Sodium Nitroprusside 25-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 234
|
Root Cause Analysis, Part 2: Sterile Compounding
Cabaleiro Joe, Jackson Kathleen
|
Mar/Apr 2016
Pg. 99-104
|
Formulation and Stability of Solutions
Akers Michael J
|
Jan/Feb 2016
Pg. 41-45
|
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 51
|
Thrombin 1,000 Units/mL Topical Solution, Sterile
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 54
|
Tropicamide 1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 55
|
Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 56
|
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Akers Michael J
|
Nov/Dec 2015
Pg. 491-500
|
Cefepime Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 505
|
Cefotaxime 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 506
|
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 507
|
Estradiol Valerate 40-mg/mL in Oil Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 509
|
Levetiracetam 100-mg/mL Injection (Concentrate)
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 510
|
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations
Donnelly Ronald F
|
Sep/Oct 2015
Pg. 383-386
|
Sterile Filtration
Akers Michael J
|
Sep/Oct 2015
Pg. 393-401
|
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
|
Jul/Aug 2015
Pg. 268-278
|
Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing
Akers Michael J
|
Jul/Aug 2015
Pg. 315-320
|
Ammonium Molybdate 25-mcg/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 324
|
Cytarabine 50-mg/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 328
|
Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 329
|
Oxytocin 10-units/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 330
|
Phytonadione 2-mg/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 331
|
Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities
Weller Tom, Kragseth Rolf, Dullinger Roger, Illum Henrik, Perry Alan
|
May/Jun 2015
Pg. 182-192
|
Quality Assurance and Quality Control, Part 2
Akers Michael J
|
May/Jun 2015
Pg. 215-221
|
Basics of Sterile Compounding: Contamination Control
Akers Michael J
|
May/Jun 2015
Pg. 232-238
|
Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2015
Pg. 246
|
Scopolamine Hydrobromide -.4-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2015
Pg. 247
|
Protocol of Blood Serum Eye Drops
Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
|
May/Jun 2015
Pg. 252-260
|
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials
Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
|
May/Jun 2015
Pg. 261-267
|
New England Compounding Center Indictment
Cabaleiro Joe
|
Mar/Apr 2015
Pg. 94-102
|
Quality Assurance and Quality Control, Part 1
Akers Michael J
|
Mar/Apr 2015
Pg. 121-124
|
Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing
Akers Michael J
|
Mar/Apr 2015
Pg. 127-138
|
Aminohippurate Sodium 200-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 143
|
L-Cysteine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 146
|
Morrhuate Sodium 5% Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 147
|
Pancuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 149
|
Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 150
|
Trypan Blue 0.06% Ophthalmic Solution
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 151
|
Basics of Sterile Compounding: Aseptic Processing
Akers Michael J
|
Jan/Feb 2015
Pg. 49-56
|
Cisplatin 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 62
|
Daunorubicin 5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 63
|
Erythromycin 50-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 64
|
Hydralazine Hydrochloride 20-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 65
|
Phentolamine Mesylate 5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 69
|
PreScription: "Named Formulas" Database Available
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 444
|
Depyrogenation Options for the Compounding Cleanroom
Weller Tom, Bell Jeff, Dullinger Roger, Allen Vern, Anthenat Bruce
|
Nov/Dec 2014
Pg. 446-454
|
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms
Akers Michael J
|
Nov/Dec 2014
Pg. 479-484
|
Dexmedetomidine 100 mcg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 495
|
Leucovorin 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 497
|
Levocarnitine 200-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 498
|
Methylene Blue 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 500
|
Oxacillin Sodium 167-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 502
|
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy
Palma Elisabetta, Bufarini Celestino
|
Sep/Oct 2014
Pg. 358-364
|
Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know
Lanze Amanda, Rudner Shara
|
Sep/Oct 2014
Pg. 397-399
|
Azithromycin 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 408
|
Dexpanthenol 250-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 410
|
Ephedrine Sulfate 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 411
|
Fluorescein 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 412
|
Indocyanine green 2.5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 413
|
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety
Johnson Kain, Sully Andrew, Anthenat Bruce
|
Jul/Aug 2014
Pg. 270-276
|
Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 313-317
|
Atracurium Besylate 10-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 322
|
Calcitriol 1-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 324
|
Chloramphenicol 100-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 325
|
Indigo Carmine Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 329
|
Propranolol Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 330
|
Zinc 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 331
|
Bupivacaine Hydrochloride 0.5% Injection
Allen Loyd V Jr
|
May/Jun 2014
Pg. 234
|
Lidocaine Hydrochloride 1% Injection
Allen Loyd V Jr
|
May/Jun 2014
Pg. 237
|
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
|
Mar/Apr 2014
Pg. 94-99
|
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding
Vu Nicole, Nguyen Devin, Kupiec Thomas C
|
Mar/Apr 2014
Pg. 123-130
|
Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 131-134
|
Fludarabine Phosphate 25-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 143
|
Mecasermin 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 144
|
Methylprednisolone 40-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 145
|
Polymixin B Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 146
|
Rocuronium Bromide 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 147
|
Selenium 40-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 149
|
Sincalide 1-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 150
|
Testosterone Enanthate 200-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 151
|
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
|
Jan/Feb 2014
Pg. 6-12
|
Determination of Risk for Sterile Preparations
Freedman ben-Horin Shimon, Rousso Tamaro
|
Jan/Feb 2014
Pg. 30-34
|
Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding
Hyde Tiffany D
|
Jan/Feb 2014
Pg. 46-52
|
Basics of Sterile Compounding: Bubble Point Testing
Thoma Laura
|
Jan/Feb 2014
Pg. 54-57
|
Aztreonam Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 60
|
Bumetanide 0.25-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 61
|
Droperidol 2.5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 62
|
Potassium Chloride 2-mEq/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 67
|
Procainamide Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 68
|
Vasopressin 20-units/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 69
|
Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies
Brensel Robert, Brensel Scott, Ng Amy
|
Nov/Dec 2013
Pg. 465-475
|
Benztropine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 498
|
Cefazolin 250-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 499
|
Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 502
|
Dihydroergotamine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 503
|
Compounding Pharmacies: Before and After an Inspection
Kulkarni Darshan, Ricketts Samantha
|
Sep/Oct 2013
Pg. 358-362
|
Acyclovir 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 414
|
Aminocaproic Acid 250-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 415
|
Clindamycin 150-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 416
|
Fluorouracil 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 417
|
Hydroxyzine Hydrochloride 25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 418
|
Indomethacin 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 419
|
Mesna 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 420
|
Methotrexate 25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 421
|
Phenylephrine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 422
|
Terbutaline Sulfate 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 423
|
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013
Newton David W
|
Jul/Aug 2013
Pg. 283-288
|
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
|
Jul/Aug 2013
Pg. 307-311
|
Allopurinol Sodium 4-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 328
|
Amikacin Sulfate 250-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 329
|
Dacarbazine 200-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 330
|
Ketamine 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 331
|
Methohexital Sodium 500-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 332
|
Metoprolol Tartrate 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 333
|
Succinylcholine Chloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 335
|
Decontamination Technology: The Missing Element
Rahe Hank
|
May/Jun 2013
Pg. 193-199
|
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines
Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
|
May/Jun 2013
Pg. 238-246
|
Sterilization of Compounded Parenteral Products: Verification of Autoclaves
Rahe Hank
|
Mar/Apr 2013
Pg. 94-98
|
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program
Griffiths Tricia, Connors Anne
|
Mar/Apr 2013
Pg. 130-134
|
Basics of Compounding: Repackaging, Part 2
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 136-140
|
Adenosine 3-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 144
|
Alcohol Dehydrated Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 145
|
Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 147
|
Cyanocobalamin 1000-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 148
|
Dexrazoxane 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 149
|
Meropenem 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 150
|
Paclitaxel 6-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 151
|
Thiotepa 15-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 152
|
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings
Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
|
Mar/Apr 2013
Pg. 168-174
|
Basics of Compounding: Repackaging, Part 1
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 54-60
|
Desmopressin 4-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 64
|
Dobutamine 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 65
|
Granisetron 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 66
|
Ibuprofen 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 67
|
Mepivacaine Hydrochloride 1% Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 68
|
Milrinone 0.2-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 69
|
Neostigmine Methylsulfate 0.5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 70
|
Nicardipine Hydrochloride Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 71
|
Octreotide 50-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 72
|
Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 73
|
Aminophylline 25-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 500
|
Ammonium Chloride 5-mEq/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 501
|
Azathioprine 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 502
|
Copper 0.4-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 503
|
Dipyridamole 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 504
|
Dopamine Hydrochloride 80-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 505
|
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 506
|
Papaverine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 507
|
Valproate Sodium 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 508
|
Vercuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 509
|
Metronidazole 5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 425
|
Doxapram Hydrochloride 20-mg/mL injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 418
|
Enalaprilat 1.25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 419
|
Esmolol Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 420
|
Fluconazole 2-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 421
|
Haloperidol 50-mg/mL in Oil Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 422
|
Meperidine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 423
|
Methocarbamol 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 424
|
Nalbuphine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 426
|
Oxymorphone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 427
|
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease
McElhiney Linda F
|
May/Jun 2012
Pg. 190-195
|
PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone
Cabaleiro Joe
|
Jan/Feb 2012
Pg. 86-87
|
Misinterpretation of United States Pharmacopeia Chapter <797>
McElhiney Linda F
|
Jan/Feb 2012
Pg. 6-10
|
Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons
James Kate, Allred Richard, Latta Kenneth S, McElhiney Linda F, Olson Jacob, Hall Richard M, Baker Chad, Armstrong Nicholas, Janik Peter, Whitehead Paul, Purcell Julian
|
Sep/Oct 2011
Pg. 390-407
|
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions
Schnatz Rick, Hernandex-Cardoso Antonio
|
May/Jun 2011
Pg. 224-232
|
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1
Latta Kenneth S, Cabaleiro Joe, Whitehead Paul, Edison Doug
|
Mar/Apr 2011
Pg. 133-144
|
PreScription: The Resources of the International Journal of Pharmaceutical Compounding, Inc.; Sterile Compounding Meets Needs for Patients, Professionals
Allen Loyd V Jr, Menighan Thomas E
|
Jan/Feb 2011
Pg. 4
|
A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management
Robinson Marian
|
Jan/Feb 2011
Pg. 20-26
|
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations
Cooper James F
|
Jan/Feb 2011
Pg. 49-54
|
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 2
Cooper James F, Chakrabarty Kaushik, McGuire Jason, Zolner William J, Jones Vann, Hedman Hilary
|
Nov/Dec 2010
Pg. 493-506
|
Home Infusion: Overcoming the Barriers to Entry
Franklin David M
|
Nov/Dec 2010
Pg. 450-455
|
Implementation of a Viable Air-Sampling Program Using a Volumetric Collection Device
Kennedy Steve, Siefert Lisa Linn, Lange Matt
|
Sep/Oct 2010
Pg. 370-372
|
Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1
Dubczak John, Latta Kenneth S, Hedman Hilary, Smith Donald R
|
Sep/Oct 2010
Pg. 407-414
|
PostScription: Guidance to Achieve Accreditation from the Pharmacy Compounding Accreditation Board
Pharmacy Compounding Accreditation Board
|
Sep/Oct 2010
Pg. 440-441
|
PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals
Menighan Thomas E
|
Jul/Aug 2010
Pg. 268
|
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together
McElhiney Linda F
|
Jul/Aug 2010
Pg. 270-274
|
Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters
Dawson Michael E
|
Jul/Aug 2010
Pg. 317-320
|
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program
Okeke Claudia C, Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 328-331
|
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations
Okeke Claudia C, Allen Loyd V Jr
|
May/Jun 2010
Pg. 232-238
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests
Allen Loyd V Jr, Okeke Claudia C
|
Mar/Apr 2010
Pg. 142-149
|
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector
Khondkar Dristi, Chopra Poonam, McArter John P, Rosen Joseph A, Li S Kevin
|
Mar/Apr 2010
Pg. 160-164
|
Ophthalmic Toning-Lubricating Drops
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 70
|
An Academic Practice Partnership: An Innovative Course in Advanced Compounding
Hale Katherine S, Hammer Dana P, Needham Shawn, Lawhorn Michelle Gaster
|
Jan/Feb 2010
Pg. 48-53
|
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control
Okeke Claudia C, Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 60-64
|
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Mixon William, Angelle Patricea (Patsy), Chang Richard I
|
Nov/Dec 2009
Pg. 506-515
|
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops
Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
|
Nov/Dec 2009
Pg. 540-543
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 16: Suggested Standard Operating Procedures
Okeke Claudia C, Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 546-553
|
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes
Bailey Caroline, Aloumanis Vasileios, Walker Brian, Ben Michel, McGuire Jason, Vu Nicole
|
Nov/Dec 2009
Pg. 564-568
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing
Okeke Claudia C, Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 420-426
|
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients
Mixon Bill, Ille Gary
|
Jul/Aug 2009
Pg. 290-294
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued)
Okeke Claudia C, Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 322-329
|
PostScription: Compounding Pharmacy in Puerto Rico
Lopez Marisol
|
Jul/Aug 2009
Pg. 350-351
|
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting
McElhiney Linda F
|
Jul/Aug 2009
Pg. 300-310
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2009
Pg. 234-238
|
Compliance by Hospitals and Healthcare Facilities with the Revised United States Pharmacopeia Chapter <797>
McElhiney Linda F
|
Mar/Apr 2009
Pg. 94-98
|
Tips for Cleanroom Construction and Renovation
Mixon William, Huffman Lanny
|
Mar/Apr 2009
Pg. 100-104
|
Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations
Latta Kenneth S, Howard Betty, Gordon Ken, Foster Lisa, Nichols Larry, Floyd Dan B, Winters Martell, Bryans Trabue
|
Mar/Apr 2009
Pg. 106-119
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 12: Sterilization Methods
Allen Loyd V Jr, Okeke Claudia C
|
Mar/Apr 2009
Pg. 146-150
|
Acidified Sodium Hypochlorite for Antisepsis and Disinfection
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 152
|
Quality Control Analytical Methods: Testing of Electrolytes Solutions
Vu Nicole
|
Jan/Feb 2009
Pg. 53-55
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2009
Pg. 56-62
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations
Allen Loyd V Jr, Okeke Claudia C
|
Sep/Oct 2008
Pg. 440-443
|
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations
Trissel Lawrence A
|
Nov/Dec 2008
Pg. 524-528
|
Glycerin, Sterile
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 542
|
Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale
Okeke Claudia C, Newton David W, Kastango Eric S, Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 530-536
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Allen Loyd V Jr, Okeke Claudia C
|
Jul/Aug 2008
Pg. 344-353
|
Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists
Mixon Bill, Cabaleiro Joe, Latta Kenneth S, Vail Jane
|
Jul/Aug 2008
Pg. 321-327
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2008
Pg. 252-257
|
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards
Kastango Eric S
|
May/Jun 2008
Pg. 216-229
|
Dilution and Compounding of Ziconotide for Intrathecal Administration
Buchta Tony, Fakata Keri, Stuart William
|
May/Jun 2008
Pg. 200-207
|
Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm!
Odegard Russell D
|
Mar/Apr 2008
Pg. 130-135
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Allen Loyd V Jr, Okeke Claudia C
|
Mar/Apr 2008
Pg. 136-144
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2008
Pg. 54-60
|
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study
Peters Gregory F, McKeon Marghi R, Nerbun Richard G
|
Nov/Dec 2007
Pg. 450-470
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics
Allen Loyd V Jr, Okeke Claudia C
|
Nov/Dec 2007
Pg. 492-499
|
Calculations: High-Technology Compounding and Investigational Dispensing
Webb Sheldon D, Stockton Shelly J
|
Nov/Dec 2007
Pg. 500-501
|
Standard Operating Procedure: Vial Crimper--Use, Care, Cleaning, and Maintenance
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 502-503
|
Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests
Kupiec Thomas C
|
Sep/Oct 2007
Pg. 400-403
|
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr, Okeke Claudia C
|
Sep/Oct 2007
Pg. 404-410
|
Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 328
|
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Okeke Claudia C
|
Jul/Aug 2007
Pg. 302-305
|
Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2
Allen Loyd V Jr, Okeke Claudia C
|
Jul/Aug 2007
Pg. 314-323
|
Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 335
|
Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2007
Pg. 230-236
|
Quality Control Analytical Methods: The Quality of Sterility Testing
McGuire Jason, Kupiec Thomas C
|
Jan/Feb 2007
Pg. 52-55
|
BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle
Benischek Rita L
|
Nov/Dec 2006
Pg. 428-433
|
Quality-Control Analytical Methods: Sterility Failure Investigations
Venti Eden M
|
Sep/Oct 2006
Pg. 372-375
|
Teaching Lab Renovation: University of Texas at Austin College of Pharmacy Combines Sterile and Nonsterile Compounding Lab Spaces
Acosta W Renee, Salzman Robert D
|
Jul/Aug 2006
Pg. 277-280
|
Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist
Zolner William J
|
Jul/Aug 2006
Pg. 281-284
|
Aseptic Compounding in New Zealand and the Use of Still Air Boxes
Gargiulo Derryn, Kairuz Therese Eileen
|
Jul/Aug 2006
Pg. 293-295
|
Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations
Douglass Kate
|
Jul/Aug 2006
Pg. 253-261
|
Putting the Science Back into the "Art and Science" of Compounding
Kastango Eric S
|
Jul/Aug 2006
Pg. 263-268
|
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate
Reed-Kane Dana, Kirshbaum Karen
|
May/Jun 2006
Pg. 165-171
|
Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor
Fields Shannon W
|
May/Jun 2006
Pg. 172
|
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns?
Tran Tuan, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2006
Pg. 202-204
|
Standard Operating Procedure: Sterility Test for Ophthalmic Solutions
Allen Loyd V Jr
|
May/Jun 2006
Pg. 218
|
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2
Wagner James T
|
May/Jun 2006
Pg. 208-211
|
Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist
Jeffrey Megan
|
Mar/Apr 2006
Pg. 113-119
|
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations
Dawson Michael F
|
Jan/Feb 2006
Pg. 36-39
|
How'd They Do That?
Roberts Jerrod L
|
Jan/Feb 2006
Pg. 46-49
|
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management
Nguyen-Xuan Tho, Griffiths William, Kern Christian, Van Gessel Elisabeth, Bonnabry Pascal
|
Jan/Feb 2006
Pg. 69-73
|
Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2005
Pg. 390
|
Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2005
Pg. 394
|
Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary)
Allen Loyd V Jr
|
Sep/Oct 2005
Pg. 395
|
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Newton David W
|
Mar/Apr 2005
Pg. 127-130
|
PostScription: Experts Everywhere
Rahe Hank
|
Mar/Apr 2005
Pg. 167
|
USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing
Caputo Ross A, Huffman Anne, Reich Robert
|
Jan/Feb 2005
Pg. 11-13
|
Using ACDs in the Practice of Pharmacy
Kastango Eric S
|
Jan/Feb 2005
Pg. 15-21
|
USP Chapter <797> and Preparing for a JCAHO Survey
McElhiney Linda F
|
Jan/Feb 2005
Pg. 23-28
|
Questions and Answers: USP Chapter <797> and JCAHO Compliance
Allen Loyd V Jr
|
Jan/Feb 2005
Pg. 29-31
|
A Dialogue Concerning Contamination Control Systems: Where Does the Isolator Fit In?
Vandenbroucke Johan, Rahe Hank
|
Jan/Feb 2005
Pg. 33-35
|
Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations
Kupiec Thomas C
|
Jan/Feb 2005
Pg. 47-49
|
Barrier Isolators, Isolators, and Glove Boxes--What's the Difference?
Rahe Hank
|
Jan/Feb 2005
Pg. 53-56
|
Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 466-467
|
Calculations
Prince Shelly J
|
Nov/Dec 2004
Pg. 468
|
Quality-Control Analytical Methods: Allowable Endotoxic Levels in Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 479-485
|
Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating
Kastango Eric S
|
Sep/Oct 2004
Pg. 393-397
|
PreScription - Categories of Pharmaceutial Compounding
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 242
|
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Newton David W, Trissel Lawrence A
|
Jul/Aug 2004
Pg. 251-263
|
Clonidine HCl 1.5-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2004
Pg. 216
|
Fluorouracil 1% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2004
Pg. 217
|
Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2004
Pg. 220
|
Testosterone Propionate 100-mg/mL in Oil Injection
Allen Loyd V Jr
|
May/Jun 2004
Pg. 222
|
Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs.
Xu Quanyun A, Trissel Lawrence A, Pham Lien
|
May/Jun 2004
Pg. 228-230
|
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction.
Trissel Lawrence A, Zhang Yanping
|
May/Jun 2004
Pg. 231-235
|
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours.
Musami Patrick, Stewart James T, Taylor E Will
|
May/Jun 2004
Pg. 236-239
|
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Rahe Hank
|
Mar/Apr 2004
Pg. 89-94
|
Netilmicin 0.455% Ophthalmic Solution
Allen Loyd V Jr
|
Mar/Apr 2004
Pg. 138
|
Pyridoxine HCl 100-mg/mL Injection, Preservative Free
Allen Loyd V Jr
|
Mar/Apr 2004
Pg. 139
|
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion
Gupta Vishnu D
|
Mar/Apr 2004
Pg. 153-155
|
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags
Lebrun John, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M
|
Mar/Apr 2004
Pg. 156-159
|
PostScription: Cleanroom Standards
Fitzpatrick Mike, Goldstein Ken
|
Mar/Apr 2004
Pg. 160
|
Glycerin 50% Injection
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 54
|
Hydrochloric Acid 0.1-N Injection
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 55
|
Phenol 5%-in-Oil Injection
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 57
|
Vancomycin HCl and Heparin Sodium Injection
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 60
|
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours
Musami Patrick, Stewart James T, Taylor E Will
|
Jan/Feb 2004
Pg. 73-76
|
Containment of Hazardous Particulates in the Compounding Pharmacy
Allen Loyd V Jr
|
Jul/Aug 2003
Pg. 281-285
|
Stability of Amikacin Sulfate in AutoDose Infusion System Bags
Zhang Yanping, Trissel Lawrence A
|
May/Jun 2003
Pg. 230-232
|
Autoclaves for the Sterilization of Compounded Parenteral Products
Rahe Hank
|
Mar/Apr 2003
Pg. 114-116
|
Technology Spotlight: Barrier Isolators
Moussa Magdy, Rahe Hank, Lo Katharine
|
Jan/Feb 2003
Pg. 42-43
|
Comparison of Endotoxin Testing Methods for Pharmaceutical Products
Joiner Timothy J, Kraus Paul F, Kupiec Thomas C
|
Nov/Dec 2002
Pg. 408-409
View Sample |
Book Review: Sterile Compounding
Reed-Kane Dana
|
Nov/Dec 2002
Pg. 414
|
Sterile Compounding of Respiratory Inhalation Solutions
Roberts Rob, Moore Eddie
|
Nov/Dec 2002
Pg. 415-417
|
Benzalkonium Chloride 1:750 Solution for Cold Disinfection
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 448
|
Furosemide 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 453
|
Phenobarbital Sodium 130-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 457
|
Cleaning and Disinfection
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 466-467
|
Sterilization of Talc for Use in Pleurodesis
Fehr Richard, Henke Michelle, Ashworth Lisa D
|
Mar/Apr 2002
Pg. 140-141
|
New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems
Kastango Eric S, Hadaway Lynn
|
Jan/Feb 2002
Pg. 55-57
|
Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures
Karolchyk Scott
|
Nov/Dec 2001
Pg. 422-423
|
Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 455
|
New Perspectives on Vancomycin Use in Home Care, Part 1
Kastango Eric S, Hadaway Lynn
|
Nov/Dec 2001
Pg. 465-469
|
Cross-contamination in Porcelain Mortars
Bauer-Brandl Annette, Falck Astrid, Ingebrigtsen Lars, Nilsen Cathrina
|
Nov/Dec 2001
Pg. 476-479
|
Quality Assurance for Sterile Products
Kastango Eric S, Douglass Kate
|
Jul/Aug 2001
Pg. 246-253
|
Sterile Compounding with Barrier-Isolation Technology
Rahe Hank
|
Jul/Aug 2001
Pg. 254-258
|
Bacterial Endotoxins and Pyrogens
Jones Marty
|
Jul/Aug 2001
Pg. 259-263
|
Evolution of the United States Pharmacopeia Chapter <1206>: "Sterile Preparations - Pharmacy Practices"
Okeke Claudia C, Barletta Frank, Newton David W, Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 265-267
|
Sterile Compounding: Excerpts from the Reviews of Current Published Literature
MacCara Mary E
|
Jul/Aug 2001
Pg. 278-279
|
Analytical Testing Facilities and Products
Hudson Sonora
|
Jul/Aug 2001
Pg. 284-286
|
Maintenance of the Cleanroom
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 313
|
Sterile-Product Preparations: Mix or Buy?
Kastango Eric S
|
Jan/Feb 2001
Pg. 59-63
|
Short Communication: Compounding for Implantable Pumps
Molitor Richard
|
Jul/Aug 2000
Pg. 280
|
Dry Heat Sterilization of Parenteral Oil Vehicles
Kupiec Thomas C, Matthews Parrish, Ahmad Riaz
|
May/Jun 2000
Pg. 223-224
|
Compounding Intrathecal Medications
Vidrine Eric
|
Jan/Feb 2000
Pg. 24-25
|
Standard Operating Procedure: Quality Assessment for Injectable Solutions
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 406-407
|
Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding
Kastango Eric S, Douglass Kate
|
Jul/Aug 1999
Pg. 253-258
|
Sterilization and Depyrogenation Principles and Methods
Akers Michael J
|
Jul/Aug 1999
Pg. 263-269
|
Sterile Product Compounding: A Comparison of ASHP and USP Guidelines
Lima Hetty A
|
Jul/Aug 1999
Pg. 270-273
|
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital
English Brett A, Riggs Robert M, Webster Andrew A, Benner Kimberly W
|
Jan/Feb 1999
Pg. 64-66
|
Testing for Bacterial Endotoxins
Jelinek Todd
|
Sep/Oct 1998
Pg. 379
|
Ophthalmic Compounding: Techniques for Achieving Sterility
Leiter Charles W
|
May/Jun 1998
Pg. 189
|
Preservation, Sterilization, and Sterility Testing of Ophthalmic Preparations
Allen Loyd V Jr
|
May/Jun 1998
Pg. 192-195
|
An Automated Process for Batch Preparation of Epidural Solutions Containing Bupivacaine Hydrochloride and Fentanyl Citrate
Rice Stephen P
|
May/Jun 1998
Pg. 214-215
|
General Aseptic Procedures Used at a Laminar Airflow Workbench
Allen Loyd V Jr
|
May/Jun 1998
Pg. 242
|
Return to Top |